Sienna Cancer Diagnostics Limited Announces Change of CEO
October 15, 2019 at 06:56 pm EDT
Sienna Cancer Diagnostics Limited announced that Matthew Hoskin will be stepping down from his role as Chief Executive Officer of the Company, and will be replaced by Carl Stubbings, currently a non-executive Director. Carl Stubbings will take up the role of CEO with immediate effect. Carl has been a non-executive Director of Sienna since 2011. Carl is a highly experienced senior leader in the biotechnology and diagnostics industries, with a focus on commercialisation, sales, marketing and business development. His most recent role was as CEO of BCAL, a private company developing a breast cancer diagnostic. He has also recently served as Commercialisation Lead at Minomic, which has commercialised a prostate cancer diagnostic, and a non-executive Director of ASXlisted Analytica. He was previously the Vice President of Sales and Marketing at Focus Diagnostics Inc. and Chief Business Officer at Benitec Biopharma.